Non-surgical treatment of locally advanced thymic epithelial tumors-a need for multicenter trials

Affiliations

Editorial

Anja C Roden. J Thorac Dis. 2016 Aug.

. 2016 Aug;8(8):1859-62.

doi: 10.21037/jtd.2016.05.66.

¹ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

No abstract available

Conflict of interest statement

The author has no conflicts of interest to declare.

Outcome of nonsurgical treatment for locally advanced thymic tumors.
Wang CL, Gao LT, Lv CX, Zhu L, Fang WT. Wang CL, et al. J Thorac Dis. 2016 Apr;8(4):705-10. doi: 10.21037/jtd.2016.01.79. J Thorac Dis. 2016. PMID: 27114838 Free PMC article.

1. Moser B, Scharitzer M, Hacker S, et al. Thymomas and thymic carcinomas: prognostic factors and multimodal management. Thorac Cardiovasc Surg 2014;62:153-60. - PubMed
1. Thomas de Montpréville V, Ghigna MR, Lacroix L, et al. Thymic carcinomas: clinicopathologic study of 37 cases from a single institution. Virchows Arch 2013;462:307-13. 10.1007/s00428-013-1371-y - DOI - PubMed
1. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77:1860-9. 10.1016/j.athoracsur.2003.10.001 - DOI - PubMed
1. Roden AC, Yi ES, Jenkins SM, et al. Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classifications. J Thorac Oncol 2015;10:691-700. 10.1097/JTO.0000000000000482 - DOI - PubMed
1. Kim ES, Putnam JB, Komaki R, et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 2004;44:369-79. 10.1016/j.lungcan.2003.12.010 - DOI - PubMed